Nisa Investment Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2K Buy
669
+42
+7% +$751 ﹤0.01% 2201
2025
Q4
$10.1K Buy
627
+118
+23% +$1.76K ﹤0.01% 2219
2025
Q3
$6.29K Buy
509
+14
+3% +$164 ﹤0.01% 2395
2025
Q2
$5.7K Buy
495
+279
+129% +$3.31K ﹤0.01% 2423
2025
Q1
$3.24K Sell
216
-2,210
-91% -$37K ﹤0.01% 2356
2024
Q4
$42K Buy
2,426
+2,339
+2,689% +$45.1K ﹤0.01% 1731
2024
Q3
$1.61K Sell
87
-18
-17% -$361 ﹤0.01% 2454
2024
Q2
$2.13K Buy
105
+5
+5% +$88 ﹤0.01% 2370
2024
Q1
$1.71K Buy
100
+82
+456% +$1.29K ﹤0.01% 2265
2023
Q4
$318 Sell
18
-1,105
-98% -$22.3K ﹤0.01% 2488
2023
Q3
$27K Hold
1,123
﹤0.01% 1915
2023
Q2
$26.1K Buy
+1,123
New +$25.4K ﹤0.01% 1996
2017
Q2
Sell
-3,917
Closed -$452K 1841
2017
Q1
$452K Sell
3,917
-3,382
-46% -$393K 0.01% 1066
2016
Q4
$876K Sell
7,299
-7,193
-50% -$796K 0.01% 851
2016
Q3
$1.63M Buy
14,492
+6,287
+77% +$724K 0.02% 632
2016
Q2
$1.02M Buy
+8,205
New +$991K 0.01% 759

Other funds holding CLB

Nisa Investment Advisors's CLB Position: Q1 2026 in Review

Nisa Investment Advisors increased its Core Laboratories (CLB) stake by 6.7% in Q1 2026, buying an estimated $751 and bringing the position to 669 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Nisa Investment Advisors first reported a position in CLB in Q2 2016 and has held it in 16 quarters since. The position peaked at $1.63M in Q3 2016. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Nisa Investment Advisors held 669 shares of Core Laboratories worth $11.2K as of Q1 2026.
  • Nisa Investment Advisors bought 42 Core Laboratories shares in Q1 2026, an estimated $751.
  • Core Laboratories made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2201 holding.
  • Nisa Investment Advisors first reported a position in Core Laboratories in Q2 2016 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Core Laboratories position peaked at $1.63M in Q3 2016.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.